Nutritional Modulation of the Intestinal Microbiota
Future Opportunities for the Prevention and Treatment of Neuroimmune and Neuroinflammatory Disease
The gut-brain-axis refers to the bidirectional communication between the enteric nervous system and the central nervous system. Mounting evidence supports the premise that the intestinal microbiota plays a pivotal role in its function and has led to the more common and perhaps more accurate term gut-microbiota-brain axis. Numerous studies have identified associations between an altered microbiome and neuroimmune and neuroinflammatory diseases. In most cases, it is unknown if these associations are cause or effect; notwithstanding, maintaining or restoring homeostasis of the microbiota may represent future opportunities when treating or preventing these diseases. In recent years, several studies have identified the diet as a primary contributing factor in shaping the composition of the gut microbiota, and in turn, the mucosal and systemic immune systems. In this review, we will discuss the potential opportunities and challenges with respect to modifying and shaping the microbiota through diet and nutrition in order to treat or prevent neuroimmune and neuroinflammatory disease.
4EPS, 4-ethylphenylsulfate, 5-HT, 5-hydroxytryptamine, AD, Alzheimer’s disease, ASD,Autism spectrum disorders, BDNF, Brain-derived neurotrophic factor, CA, Catecholamines, CDCrohn’s disease, CNS,Central nervous system, DHA, Docosahexaenoic acid, EAE, Experimental autoimmune encephalomyelitis, ENS, Enteric nervous system, EPA, Eicosapentaenoic acid, FEP, First episode psychosis, GABA, Gamma-aminobutyric acid, GALT, Gut-associated lymphoid tissues, GIGastrointestinal, HIV, Human immunodeficiency virus, HAART, Highly active antiretroviral therapy, IBS, Irritable bowel syndrome, IDO, Indoleamine 2,3-dioxygenase, IL, Interleukin, LCFAs, Long-chain fatty acids, ME, Myalgic encephalomyelitis, MIA, Maternal immune activation, MS, Multiple sclerosis, NMDA, N-methyl-D-aspartate, PD, Parkinson’s diseasepoly I:C, Polyinosinic:polycytidylic, RRMS,Relapsing-remitting MS; SCFAs, Short-chain fatty acids; SIV, Simian immunodeficiency virus; TLF, Toll-like receptor; TNF-αTumor necrosis factor-alpha, TregsRegulatory, T cells; vA, Vitamin A; vD, Vitamin D; VDR, Vitamin D receptor
Microbiomene; urocognitivegut-microbiota-brain axis; SCFA; neurotrophic; vitamin; oxidative stress; polyphenols; myalgic encephalomyelitis; Parkinson’s disease; Alzheimer’s Disease; autism; multiple sclerosis’ schizophreniaBack to "Blog"